SEGMENTS COVERED IN THE REPORT ARE AS FOLLOWS:

This report projected revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2032. For this study, Quintile Insights have segmented the veterinary in vitro fertilization (IVF) market report based on product type, technique, end-use, and region:

By Product Type: Revenue in USD Million (2017 - 2032)  

o   Reagents  

o   Equipment    

o   Services

By Technique: Revenue in USD Million (2017 - 2032) 

o   Artificial insemination      

o   Embryo Transfer

By End Use: Revenue in USD Million (2017 - 2032)     

o   Fertility Clinics & Surgical Centers

o   Hospital     

o   Research Laboratories     

o   Cyrobanks

Regional insights: Revenue in USD Million (2017 - 2032)

o   North America (U.S., Canada)

o   Europe (U.K., Germany, France, Italy, and Spain)

o   Asia Pacific (Japan, China, India, Australia, South Korea, and Singapore)

o   Latin America (Brazil, Mexico, Argentina, and Colombia)

o   Middle East & Africa (Saudi Arabia, UAE, and South Africa)

Frequently Asked Questions


The global veterinary in vitro fertilization (IVF) market is predicted to develop at a compound annual growth rate of 6.50 % from 2022-2032 to reach up to USD 7.54 billion by 2032

The global veterinary in vitro fertilization (IVF) market was valued at USD 3.80 billion in 2021 and is expected to reach USD 4.02 billion in 2022

Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of emerging countries. This is due to the presence of a large livestock population in this region. increasing demand for milk and animal-based protein, along with government initiatives, is propelling the market growth

Some of the key market players operating in the Veterinary in Vitro Fertilization (IVF) market are Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditec, Swine Genetics International Select Sires Inc. SEMEX

Increased utilization of veterinary artificial insemination (AI) and government support that has an impact on animal health services are the two main factors propelling the global veterinary artificial reproduction market. Semen contamination, however, is anticipated to hinder expansion. The coronavirus pandemic has affected the worldwide supply chain, which has led to a shortage of animal health supplies including organic feed.